thyroxine has been researched along with Preterm Birth in 62 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Excerpt | Relevance | Reference |
---|---|---|
"Currently, there is no consensus on universal thyroid screening and levothyroxine (LT4) treatment of pregnant women with subclinical hypothyroidism (SCH) who are negative for thyroid peroxidase antibody (TPOAb-)." | 9.27 | Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies. ( Azizi, F; Minooee, S; Nazarpour, S; Rahmati, M; Ramezani Tehrani, F; Simbar, M; Tohidi, M, 2018) |
"Levothyroxine sodium in the treatment of SCH can significantly reduce the incidence of premature birth, miscarriage, postpartum hemorrhage, and low birth weight infants." | 9.22 | Systematic review and meta-analysis of the efficacy and pregnancy outcomes of levothyroxine sodium tablet administration in pregnant women complicated with hypothyroidism. ( Chen, Y; Geng, X; Li, N; Ma, J; Sun, C; Wang, W; Wu, W, 2022) |
"Several systematic reviews and meta-analyses have investigated the effect of levothyroxine (LT4) therapy in pregnant women with subclinical hypothyroidism (SCH)." | 9.22 | The impact of levothyroxine therapy on the pregnancy, neonatal and childhood outcomes of subclinical hypothyroidism during pregnancy: An updated systematic review, meta-analysis and trial sequential analysis. ( Chen, J; Jiao, XF; Li, H; Liu, D; Wei, Q; Zeng, L; Zhang, C; Zhang, L; Zhang, M; Zou, K, 2022) |
"To evaluate the effect of levothyroxine therapy on pregnancy outcomes compared with placebo or no treatment in women without overt hypothyroidism with presence of thyroid peroxidase antibodies (TPOAb) and/or thyroglobulin antibodies (TgAb)." | 9.12 | Impact of levothyroxine in women with positive thyroid antibodies on pregnancy outcomes: a systematic review and meta-analysis of randomised controlled trials. ( Benham, JL; Donovan, LE; Lau, L; Lemieux, P; Yamamoto, J, 2021) |
" The following terms were used for the search: [subclinical hypothyroidism OR thyroid autoimmunity OR thyroperoxidase antibody (TPO-Ab) OR thyroglobulin antibodies (Tg-Ab)] AND (levothyroxine OR euthyrox) AND [pregnancy outcome OR miscarriage OR abortion OR pregnancy loss OR preterm birth OR premature delivery OR early labo(u)r]." | 9.01 | Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta-analysis. ( Liu, J; Rao, M; Su, C; Su, Z; Tang, L; Wang, H; Wang, R; Wen, Y; Yang, Z; Zeng, Z; Zhao, S; Zhou, F, 2019) |
"To study the effects of third trimester maternal isolated hypothyroxinemia (serum low free thyroxine and normal thyroid stimulating hormone level) on pregnancy outcomes, we performed a retrospective cohort study in women with singleton pregnancy between February 2009 and June 2012." | 8.31 | Association between third trimester maternal isolated hypothyroxinemia and adverse pregnancy outcomes. ( Chen, L; Lin, D; Lin, H; Lin, Z; Lu, X; Peng, M; Sun, M; Ye, E; Yu, L, 2023) |
"This study was undertaken to test the therapeutic effect of extra-low dose of levothyroxine (LT4; 25 mcg/day) to preconception and pregnant women with subclinical hypothyroidism (SCH)." | 8.31 | Effect of extra-low dose levothyroxine supplementation on pregnancy outcomes in women with subclinical hypothyroidism undergoing in vitro fertilization and embryo transfer. ( Chen, YT; Chung, MT; Ho, CH; Hsiao, TW; Lin, YL; Tsai, YC; Wen, JY, 2023) |
"The influence of maternal levothyroxine treatment during pregnancy remains unclear." | 8.12 | Association of maternal levothyroxine use during pregnancy with offspring birth and neurodevelopmental outcomes: a population-based cohort study. ( Cheung, CL; Cheung, ECL; Ge, GM; Ip, P; Kung, AWC; Leung, WC; Li, GHY; Man, KKC; Wong, ICK, 2022) |
"The aims were to establish a gestational-age specific curve for serum total thyroxine (T4) levels and to compare pregnancy outcomes of euthyroid women with those identified to have subclinical hypothyroidism (SCH) defined by an elevated thyroid-stimulating hormone (TSH) level in conjunction with either total T4 or free T4 determinations." | 7.80 | Is total thyroxine better than free thyroxine during pregnancy? ( Casey, BM; Cunningham, FG; McIntire, DD; Wilson, KL, 2014) |
"This was a secondary analysis of two parallel multicenter clinical trials of thyroxine therapy for subclinical hypothyroid disorders in pregnancy." | 5.51 | Association between Hypertensive Disorders of Pregnancy and Long-Term Neurodevelopmental Outcomes in the Offspring. ( Caritis, SN; Casey, BM; Costantine, MM; Mele, L; Mercer, BM; Palatnik, A; Reddy, UM; Rouse, DJ; Saade, GR; Sibai, B; Sorokin, Y; Thorp, JM; Tita, ATN; Tolosa, JE; Varner, MW; Wapner, RJ, 2022) |
"Currently, there is no consensus on universal thyroid screening and levothyroxine (LT4) treatment of pregnant women with subclinical hypothyroidism (SCH) who are negative for thyroid peroxidase antibody (TPOAb-)." | 5.27 | Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies. ( Azizi, F; Minooee, S; Nazarpour, S; Rahmati, M; Ramezani Tehrani, F; Simbar, M; Tohidi, M, 2018) |
"Several systematic reviews and meta-analyses have investigated the effect of levothyroxine (LT4) therapy in pregnant women with subclinical hypothyroidism (SCH)." | 5.22 | The impact of levothyroxine therapy on the pregnancy, neonatal and childhood outcomes of subclinical hypothyroidism during pregnancy: An updated systematic review, meta-analysis and trial sequential analysis. ( Chen, J; Jiao, XF; Li, H; Liu, D; Wei, Q; Zeng, L; Zhang, C; Zhang, L; Zhang, M; Zou, K, 2022) |
"Levothyroxine sodium in the treatment of SCH can significantly reduce the incidence of premature birth, miscarriage, postpartum hemorrhage, and low birth weight infants." | 5.22 | Systematic review and meta-analysis of the efficacy and pregnancy outcomes of levothyroxine sodium tablet administration in pregnant women complicated with hypothyroidism. ( Chen, Y; Geng, X; Li, N; Ma, J; Sun, C; Wang, W; Wu, W, 2022) |
"To evaluate the effect of levothyroxine therapy on pregnancy outcomes compared with placebo or no treatment in women without overt hypothyroidism with presence of thyroid peroxidase antibodies (TPOAb) and/or thyroglobulin antibodies (TgAb)." | 5.12 | Impact of levothyroxine in women with positive thyroid antibodies on pregnancy outcomes: a systematic review and meta-analysis of randomised controlled trials. ( Benham, JL; Donovan, LE; Lau, L; Lemieux, P; Yamamoto, J, 2021) |
"Among pregnant women without overt thyroid disease, subclinical hypothyroidism, isolated hypothyroxinemia, and TPO antibody positivity were significantly associated with higher risk of preterm birth." | 5.01 | Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis. ( Alexander, EK; Auvinen, J; Bassols, J; Bliddal, S; Boucai, L; Bramer, WM; Brown, SJ; Carty, DM; Chaker, L; Chatzi, L; Chen, L; Dayan, C; Delles, C; Derakhshan, A; Feldt-Rasmussen, U; Ghafoor, F; Grineva, EN; Guxens, M; Hisada, A; Jiménez-Zabala, A; Korevaar, TIM; López-Bermejo, A; Lu, X; Männistö, T; Meems, M; Meima, M; Mosso, L; Mukhtar, S; Murcia, M; Nelson, SM; Oken, E; Pearce, EN; Peeters, RP; Pop, VJM; Popova, PV; Riaño, I; Shields, B; Steegers, EAP; Sunyer, J; Suvanto, E; Taylor, PN; Tkachuck, AS; Vafeiadi, M; Vaidya, B; Vrijkotte, TG; Walsh, JP; Yoshinaga, J, 2019) |
" The following terms were used for the search: [subclinical hypothyroidism OR thyroid autoimmunity OR thyroperoxidase antibody (TPO-Ab) OR thyroglobulin antibodies (Tg-Ab)] AND (levothyroxine OR euthyrox) AND [pregnancy outcome OR miscarriage OR abortion OR pregnancy loss OR preterm birth OR premature delivery OR early labo(u)r]." | 5.01 | Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta-analysis. ( Liu, J; Rao, M; Su, C; Su, Z; Tang, L; Wang, H; Wang, R; Wen, Y; Yang, Z; Zeng, Z; Zhao, S; Zhou, F, 2019) |
"The impact of subclinical hypothyroidism (SCH) and of levothyroxine replacement in pregnant women with SCH is unclear." | 4.93 | Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. ( Coddington, CC; Erwin, PJ; Espinosa De Ycaza, AE; Gionfriddo, MR; Maraka, S; Montori, VM; Murad, MH; O'Keeffe, DT; Ospina, NM; Stan, MN, 2016) |
" In one trial of 115 women, levothyroxine therapy to treat pregnant euthyroid (normal thyroid function) women with thyroid peroxidase antibodies was not shown to reduce pre-eclampsia significantly (risk ratio (RR) 0." | 4.89 | Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy. ( Bain, E; Cossich, MC; Crowther, CA; Middleton, P; Reid, SM, 2013) |
" To assess the effect of treatment with levothyroxine on pregnancy outcomes in this group of women." | 4.87 | Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. ( Coomarasamy, A; Franklyn, J; Kilby, MD; Knox, E; Tan, A; Thangaratinam, S, 2011) |
" In one trial of 115 women, levothyroxine therapy to treat pregnant euthyroid women with thyroid peroxidase antibodies was not shown to reduce pre-eclampsia significantly (risk ratio (RR) 0." | 4.86 | Interventions for clinical and subclinical hypothyroidism in pregnancy. ( Cossich, MC; Crowther, CA; Middleton, P; Reid, SM, 2010) |
"92 mIU/L; these women may benefit from Levothyroxine (LT4) therapy for preventing preterm birth." | 4.31 | A Bayesian model to estimate the cutoff value of TSH for management of preterm birth. ( Azizi, F; Behboudi-Gandevani, S; Minooee, S; Nazarpour, S; Rahmati, M; Tehrani, FR, 2023) |
"To study the effects of third trimester maternal isolated hypothyroxinemia (serum low free thyroxine and normal thyroid stimulating hormone level) on pregnancy outcomes, we performed a retrospective cohort study in women with singleton pregnancy between February 2009 and June 2012." | 4.31 | Association between third trimester maternal isolated hypothyroxinemia and adverse pregnancy outcomes. ( Chen, L; Lin, D; Lin, H; Lin, Z; Lu, X; Peng, M; Sun, M; Ye, E; Yu, L, 2023) |
"This study was undertaken to test the therapeutic effect of extra-low dose of levothyroxine (LT4; 25 mcg/day) to preconception and pregnant women with subclinical hypothyroidism (SCH)." | 4.31 | Effect of extra-low dose levothyroxine supplementation on pregnancy outcomes in women with subclinical hypothyroidism undergoing in vitro fertilization and embryo transfer. ( Chen, YT; Chung, MT; Ho, CH; Hsiao, TW; Lin, YL; Tsai, YC; Wen, JY, 2023) |
"The influence of maternal levothyroxine treatment during pregnancy remains unclear." | 4.12 | Association of maternal levothyroxine use during pregnancy with offspring birth and neurodevelopmental outcomes: a population-based cohort study. ( Cheung, CL; Cheung, ECL; Ge, GM; Ip, P; Kung, AWC; Leung, WC; Li, GHY; Man, KKC; Wong, ICK, 2022) |
" There is insufficient evidence to recommend for or against therapy with triiodothyronine (T3), apart from in pregnancy when only levothyroxine is indicated, as T3 does not sufficiently cross fetal blood‑brain barrier." | 4.12 | Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. ( Klubo-Gwiezdzinska, J; Wartofsky, L, 2022) |
"At median 10, 18, and 26 weeks of gestation, we observed significant inverse associations between free thyroxine (FT4) and birth weight z scores, with the strongest association detected at median 10 weeks, at which time a 10% increase in FT4 was associated with a 0." | 3.88 | Subclinical Changes in Maternal Thyroid Function Parameters in Pregnancy and Fetal Growth. ( Cantonwine, DE; Ferguson, KK; Johns, LE; McElrath, TF; Meeker, JD; Mukherjee, B, 2018) |
"The isolated hypothyroxinemia of pregnancy (IHP) has gained specific attention in the specialized literature during the recent years as the possible factor impeding the intellectual development of fetus and increasing the risk of complications related with pregnancy, delivery and perinatal period." | 3.88 | IMPORTANCE OF ISOLATED GESTATIONAL HYPOTHYROXINEMIA IN THE DEVELOPMENT OF OBSTETRIC AND SOMATIC PATHOLOGIES. ( Gagua, D; Gagua, T; Morchiladze, N; Tkeshelashvili, B, 2018) |
"Thyrotropin (TSH), free thyroxine (FT4), TPOAbs, and/or hCG concentrations were measured in early and late pregnancy of 7587 pregnant women from 2 Dutch population-based prospective cohorts (n = 5924, Generation R study; n = 1663, Holistic Approach to Pregnancy and the First Postpartum Year study)." | 3.85 | Thyroid Autoimmunity Impairs the Thyroidal Response to Human Chorionic Gonadotropin: Two Population-Based Prospective Cohort Studies. ( Broeren, MA; Chaker, L; de Rijke, YB; Jaddoe, VW; Korevaar, TI; Medici, M; Peeters, RP; Pop, VJ; Steegers, EA; Tiemeier, H; Visser, TJ, 2017) |
"The aims were to establish a gestational-age specific curve for serum total thyroxine (T4) levels and to compare pregnancy outcomes of euthyroid women with those identified to have subclinical hypothyroidism (SCH) defined by an elevated thyroid-stimulating hormone (TSH) level in conjunction with either total T4 or free T4 determinations." | 3.80 | Is total thyroxine better than free thyroxine during pregnancy? ( Casey, BM; Cunningham, FG; McIntire, DD; Wilson, KL, 2014) |
" All women were treated with levothyroxine (L-T₄) during pregnancy." | 3.79 | Pregnancy outcomes in women with severe hypothyroidism. ( Hirsch, D; Kopel, V; Levy, S; Nadler, V; Shainberg, B; Toledano, Y, 2013) |
"Pregnancy is a complex state with many endocrinological challenges to a woman's physiology." | 2.72 | Understanding the Pathogenesis of Gestational Hypothyroidism. ( Li, X; Mallawa Kankanamalage, O; Zhou, Q, 2021) |
"Hypothyroidism in pregnancy is defined as the presence of an elevated thyroid stimulating hormone during gestation, affecting 2% to 3% of the population." | 2.61 | Hypothyroidism in Pregnancy. ( Sullivan, SA, 2019) |
"Hypothyroidism is one of the most prevalent diseases in pregnancy, but there is no consensus about its management in pregnant women." | 2.58 | Pregnancy Complications Associated With Maternal Hypothyroidism: A Systematic Review. ( Aristides, SMA; de Carvalho, HC; Demarchi, IG; Günther, LSA; Lopes, LCB; Santos, TDS; Shinohara, DR; Teixeira, JJV, 2018) |
"Subclinical hypothyroidism has been found to be associated with adverse reproductive outcomes, such as infertility, miscarriage, preterm birth, and complications of pregnancy." | 2.53 | The Impact and Management of Subclinical Hypothyroidism for Improving Reproductive Outcomes such as Fertility and Miscarriage. ( Seungdamrong, A, 2016) |
"If left untreated, both hypothyroidism and hyperthyroidism are associated with adverse effects on pregnancy and fetal outcomes." | 2.48 | Thyroid disorders during pregnancy. ( Sullivan, SD; Yazbeck, CF, 2012) |
"Although the frequency of miscarriage in the AT group was greater (4." | 1.72 | Thyroid Function Rather Than Thyroid Antibodies Affects Pregnancy and Perinatal Outcomes: Results of a Prospective Study. ( Bagattini, B; Benelli, E; Fiore, E; Gianetti, E; Montanelli, L; Orsolini, F; Terrenzio, C; Tonacchera, M, 2022) |
"Hyperthyroidism was associated with an increased risk of preterm birth (PTB, adjusted OR: 2." | 1.62 | Impact of maternal thyroid hormone in late pregnancy on adverse birth outcomes: A retrospective cohort study in China. ( Gao, Y; Wang, H; Wang, J; Yu, B; Yuan, X, 2021) |
"Maternal hypothyroidism has been reported to have concerns over neonatal outcomes, not only in the context of neurocognitive development but also in the short term as birth weight and neonatal jaundice." | 1.62 | Neonatal outcomes and congenital anomalies in pregnancies affected by hypothyroidism. ( Humayun, KN; Islam, N; Kiran, Z; Sheikh, A, 2021) |
"Gestational hypertension was least likely to occur in thyroid autoimmune groups." | 1.62 | Association of thyroid antibodies status on the outcomes of pregnant women with hypothyroidism (maternal hypothyroidism on pregnancy outcomes, MHPO-4). ( Islam, N; Kiran, Z; Sheikh, A, 2021) |
"Maternal hypothyroidism is associated with several pregnancy and perinatal complications, but consistent LT4 use may reduce many of the risks." | 1.51 | Pregnancy and Perinatal Outcome Among Hypothyroid Mothers: A Population-Based Cohort Study. ( Gissler, M; Hartikainen, AL; Lahesmaa-Korpinen, AM; Männistö, T; Suvanto, E; Turunen, S; Vääräsmäki, M, 2019) |
"The rate of miscarriage did not differ between the 3 groups (11." | 1.43 | Impact of Levothyroxine in Miscarriage and Preterm Delivery Rates in First Trimester Thyroid Antibody-Positive Women With TSH Less Than 2.5 mIU/L. ( Negro, R; Schwartz, A; Stagnaro-Green, A, 2016) |
"The incidence of the pregnancy complications in the TPOAb (+) treated group was higher than those in the control group, but the differences were not statistically significant (P > 0." | 1.42 | [Effect of the treatment acceptance on the perinatal outcomes in women with subclinical hypothyroidism, positive thyroid gland peroxidase antibody in early pregnancy]. ( Ding, S; Guo, H; Tao, B; Yang, J; Zhang, X, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (3.23) | 29.6817 |
2010's | 32 (51.61) | 24.3611 |
2020's | 28 (45.16) | 2.80 |
Authors | Studies |
---|---|
Nazarpour, S | 5 |
Ramezani Tehrani, F | 4 |
Rahmati, M | 4 |
Amiri, M | 3 |
Azizi, F | 6 |
Kiran, Z | 2 |
Sheikh, A | 2 |
Humayun, KN | 1 |
Islam, N | 2 |
Palatnik, A | 1 |
Mele, L | 1 |
Casey, BM | 2 |
Varner, MW | 1 |
Sorokin, Y | 1 |
Reddy, UM | 1 |
Wapner, RJ | 1 |
Thorp, JM | 1 |
Saade, GR | 1 |
Tita, ATN | 1 |
Rouse, DJ | 1 |
Sibai, B | 1 |
Costantine, MM | 1 |
Mercer, BM | 1 |
Tolosa, JE | 1 |
Caritis, SN | 1 |
Ding, Z | 1 |
Liu, Y | 1 |
Maraka, S | 3 |
Abdelouahab, N | 1 |
Huang, HF | 2 |
Fraser, WD | 2 |
Fan, J | 3 |
Meng, Y | 1 |
Lin, J | 1 |
Klubo-Gwiezdzinska, J | 1 |
Wartofsky, L | 1 |
Sheidaei, A | 1 |
Geng, X | 1 |
Chen, Y | 1 |
Wang, W | 1 |
Ma, J | 1 |
Wu, W | 1 |
Li, N | 2 |
Sun, C | 1 |
Korevaar, TIM | 2 |
Jiao, XF | 1 |
Zhang, M | 1 |
Chen, J | 1 |
Wei, Q | 1 |
Zeng, L | 1 |
Liu, D | 1 |
Zhang, C | 3 |
Li, H | 1 |
Zou, K | 1 |
Zhang, L | 2 |
Orsolini, F | 1 |
Gianetti, E | 1 |
Terrenzio, C | 1 |
Montanelli, L | 1 |
Benelli, E | 1 |
Bagattini, B | 1 |
Fiore, E | 1 |
Tonacchera, M | 2 |
Xie, T | 1 |
Tan, M | 1 |
Jiang, X | 1 |
Feng, Y | 1 |
Chen, Q | 1 |
Mei, H | 1 |
Cai, Y | 1 |
Zou, H | 1 |
Huang, Y | 1 |
Ge, GM | 1 |
Cheung, ECL | 1 |
Man, KKC | 1 |
Ip, P | 1 |
Leung, WC | 1 |
Li, GHY | 1 |
Kung, AWC | 1 |
Cheung, CL | 1 |
Wong, ICK | 1 |
Zhuo, L | 3 |
Wang, Z | 3 |
Yang, Y | 3 |
Liu, Z | 3 |
Wang, S | 3 |
Song, Y | 3 |
Han, Y | 1 |
Gao, X | 1 |
Wang, X | 1 |
Gong, B | 1 |
Peng, B | 1 |
Li, J | 1 |
Liu, A | 1 |
Shan, Z | 1 |
Minooee, S | 2 |
Behboudi-Gandevani, S | 1 |
Tehrani, FR | 1 |
Chen, L | 2 |
Ye, E | 1 |
Sun, M | 1 |
Lin, H | 1 |
Yu, L | 1 |
Lin, Z | 1 |
Peng, M | 1 |
Lin, D | 1 |
Lu, X | 2 |
Yu, M | 1 |
Long, Y | 1 |
Wang, Y | 2 |
Zhang, R | 1 |
Tao, L | 1 |
Chen, YT | 1 |
Ho, CH | 1 |
Chung, MT | 1 |
Wen, JY | 1 |
Lin, YL | 1 |
Hsiao, TW | 1 |
Tsai, YC | 1 |
Derakhshan, A | 1 |
Taylor, PN | 1 |
Meima, M | 1 |
Bliddal, S | 2 |
Carty, DM | 1 |
Meems, M | 1 |
Vaidya, B | 1 |
Shields, B | 1 |
Ghafoor, F | 1 |
Popova, PV | 1 |
Mosso, L | 1 |
Oken, E | 1 |
Suvanto, E | 2 |
Hisada, A | 1 |
Yoshinaga, J | 1 |
Brown, SJ | 1 |
Bassols, J | 1 |
Auvinen, J | 1 |
Bramer, WM | 1 |
López-Bermejo, A | 1 |
Dayan, C | 1 |
Boucai, L | 1 |
Vafeiadi, M | 1 |
Grineva, EN | 1 |
Tkachuck, AS | 1 |
Pop, VJM | 1 |
Vrijkotte, TG | 1 |
Guxens, M | 1 |
Chatzi, L | 1 |
Sunyer, J | 1 |
Jiménez-Zabala, A | 1 |
Riaño, I | 1 |
Murcia, M | 2 |
Mukhtar, S | 1 |
Delles, C | 1 |
Feldt-Rasmussen, U | 2 |
Nelson, SM | 1 |
Alexander, EK | 1 |
Chaker, L | 2 |
Männistö, T | 2 |
Walsh, JP | 1 |
Pearce, EN | 2 |
Steegers, EAP | 1 |
Peeters, RP | 3 |
Tosun, G | 1 |
Kose, S | 1 |
İşbilen Başok, B | 1 |
Altunyurt, S | 1 |
Cigrovski Berković, M | 1 |
Herman Mahečić, D | 1 |
Marinković Radošević, J | 1 |
Strinović Morić, M | 1 |
Bilić-Ćurčić, I | 1 |
Yang, X | 1 |
Yu, Y | 1 |
Zhang, Y | 1 |
Chen, Z | 1 |
Dubois, L | 1 |
Yuan, X | 1 |
Wang, J | 1 |
Gao, Y | 1 |
Wang, H | 2 |
Yu, B | 1 |
Cheng, WL | 1 |
Liu, XR | 1 |
Zuo, Y | 1 |
Zheng, W | 1 |
Wu, SS | 1 |
Jiang, B | 1 |
Lau, L | 1 |
Benham, JL | 1 |
Lemieux, P | 1 |
Yamamoto, J | 1 |
Donovan, LE | 1 |
Mallawa Kankanamalage, O | 1 |
Zhou, Q | 1 |
Li, X | 1 |
Aung, MT | 1 |
Johns, LE | 2 |
Ferguson, KK | 2 |
Mukherjee, B | 2 |
McElrath, TF | 2 |
Meeker, JD | 2 |
Plowden, TC | 1 |
Schisterman, EF | 1 |
Sjaarda, LA | 1 |
Perkins, NJ | 1 |
Silver, R | 1 |
Radin, R | 1 |
Kim, K | 1 |
Galai, N | 1 |
DeCherney, AH | 1 |
Mumford, SL | 1 |
Simbar, M | 1 |
Tohidi, M | 1 |
Cantonwine, DE | 1 |
Eerdekens, A | 1 |
Langouche, L | 1 |
Güiza, F | 1 |
Verhaeghe, J | 1 |
Naulaers, G | 1 |
Vanhole, C | 1 |
Van den Berghe, G | 1 |
Shinohara, DR | 1 |
Santos, TDS | 1 |
de Carvalho, HC | 1 |
Lopes, LCB | 1 |
Günther, LSA | 1 |
Aristides, SMA | 1 |
Teixeira, JJV | 1 |
Demarchi, IG | 1 |
Morchiladze, N | 1 |
Tkeshelashvili, B | 1 |
Gagua, T | 1 |
Gagua, D | 1 |
Turunen, S | 1 |
Vääräsmäki, M | 1 |
Hartikainen, AL | 1 |
Lahesmaa-Korpinen, AM | 1 |
Gissler, M | 1 |
Rao, M | 1 |
Zeng, Z | 1 |
Zhou, F | 1 |
Liu, J | 1 |
Wang, R | 1 |
Wen, Y | 1 |
Yang, Z | 1 |
Su, C | 1 |
Su, Z | 1 |
Zhao, S | 1 |
Tang, L | 1 |
Sullivan, SA | 1 |
Reid, SM | 2 |
Middleton, P | 2 |
Cossich, MC | 2 |
Crowther, CA | 2 |
Bain, E | 1 |
Hirsch, D | 1 |
Levy, S | 1 |
Nadler, V | 1 |
Kopel, V | 1 |
Shainberg, B | 1 |
Toledano, Y | 1 |
Korevaar, TI | 2 |
Schalekamp-Timmermans, S | 1 |
de Rijke, YB | 2 |
Visser, WE | 1 |
Visser, W | 1 |
de Muinck Keizer-Schrama, SM | 1 |
Hofman, A | 1 |
Ross, HA | 1 |
Hooijkaas, H | 1 |
Tiemeier, H | 2 |
Bongers-Schokking, JJ | 1 |
Jaddoe, VW | 2 |
Visser, TJ | 2 |
Steegers, EA | 2 |
Medici, M | 2 |
Wilson, KL | 1 |
McIntire, DD | 1 |
Cunningham, FG | 1 |
León, G | 1 |
Rebagliato, M | 1 |
Álvarez-Pedrerol, M | 1 |
Castilla, AM | 1 |
Basterrechea, M | 1 |
Iñiguez, C | 1 |
Fernández-Somoano, A | 1 |
Blarduni, E | 1 |
Foradada, CM | 1 |
Tardón, A | 1 |
Vioque, J | 1 |
Boas, M | 1 |
Hilsted, L | 1 |
Friis-Hansen, L | 1 |
Tabor, A | 1 |
Hou, J | 1 |
Yu, P | 1 |
Zhu, H | 1 |
Pan, H | 1 |
Yang, H | 1 |
Jiang, Y | 1 |
Wang, L | 1 |
Wang, B | 1 |
You, L | 1 |
Chen, S | 1 |
Yang, J | 1 |
Guo, H | 1 |
Ding, S | 1 |
Tao, B | 1 |
Zhang, X | 1 |
Ospina, NM | 1 |
O'Keeffe, DT | 2 |
Espinosa De Ycaza, AE | 2 |
Gionfriddo, MR | 1 |
Erwin, PJ | 1 |
Coddington, CC | 2 |
Stan, MN | 2 |
Murad, MH | 1 |
Montori, VM | 2 |
Singh Ospina, NM | 1 |
Rodriguez-Gutierrez, R | 1 |
Wi, CI | 1 |
Juhn, YJ | 1 |
Zhang, SC | 1 |
Wang, SW | 1 |
Zhao, XD | 1 |
Zhang, JR | 1 |
Negro, R | 1 |
Schwartz, A | 1 |
Stagnaro-Green, A | 1 |
Seungdamrong, A | 1 |
Pop, VJ | 1 |
Broeren, MA | 1 |
Benvenga, S | 1 |
Ordookhani, A | 1 |
Braverman, LE | 1 |
Tierney, K | 1 |
Delpachitra, P | 1 |
Grossmann, M | 1 |
Onwude, J | 1 |
Sikaris, K | 1 |
Wallace, EM | 1 |
Hamilton, EJ | 1 |
Tong, S | 1 |
Simic, N | 1 |
Westall, C | 1 |
Astzalos, EV | 1 |
Rovet, J | 1 |
Ashoor, G | 1 |
Maiz, N | 1 |
Rotas, M | 1 |
Jawdat, F | 1 |
Nicolaides, KH | 1 |
Thangaratinam, S | 1 |
Tan, A | 1 |
Knox, E | 1 |
Kilby, MD | 1 |
Franklyn, J | 1 |
Coomarasamy, A | 1 |
Leitner, AY | 1 |
Pellegrini, F | 1 |
Beck-Peccoz, P | 1 |
Wanker, P | 1 |
Persani, L | 1 |
Radetti, G | 1 |
Yazbeck, CF | 1 |
Sullivan, SD | 1 |
Williams, F | 1 |
Watson, J | 1 |
Ogston, S | 1 |
Hume, R | 1 |
Willatts, P | 1 |
Visser, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.[NCT00467363] | 1,228 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Partial or complete abruption (ie, premature separation of the placenta) (NCT00467363)
Timeframe: until delivery
Intervention | participants (Number) |
---|---|
Aspirin | 7 |
Placebo | 5 |
(NCT00467363)
Timeframe: 8-weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 374 |
Placebo | 346 |
Implantation failures (NCT00467363)
Timeframe: 8 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 28 |
Placebo | 27 |
(NCT00467363)
Timeframe: within 6 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 3 |
Placebo | 3 |
(NCT00467363)
Timeframe: until 40 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 4 |
Placebo | 6 |
(NCT00467363)
Timeframe: within 8-weeks of gestation
Intervention | pregnancy (Number) |
---|---|
Aspirin | 394 |
Placebo | 363 |
Live birth was obtained prospectively by maternal report and abstraction from medical records by trained staff . (NCT00467363)
Timeframe: after delivery
Intervention | livebirths (Number) |
---|---|
Aspirin | 309 |
Placebo | 286 |
(NCT00467363)
Timeframe: 8 weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 0 |
Placebo | 0 |
(NCT00467363)
Timeframe: until delivery
Intervention | participants (Number) |
---|---|
Aspirin | 32 |
Placebo | 30 |
Includes preembryonic and embryonic losses (exclusive of implantation failures) (NCT00467363)
Timeframe: less than 10-weeks
Intervention | pregnancy (Number) |
---|---|
Aspirin | 56 |
Placebo | 53 |
(NCT00467363)
Timeframe: until delivery
Intervention | infants (Number) |
---|---|
Aspirin | 22 |
Placebo | 31 |
birthweight (NCT00467363)
Timeframe: until delivery
Intervention | grams (Mean) |
---|---|
Aspirin | 3327 |
Placebo | 3315 |
(NCT00467363)
Timeframe: 40 weeks
Intervention | participants (Number) |
---|---|
Aspirin | 2 |
Placebo | 2 |
21 reviews available for thyroxine and Preterm Birth
Article | Year |
---|---|
Pregnancy and Neonatal Outcomes With Levothyroxine Treatment in Women With Subclinical Hypothyroidism Based on New Diagnostic Criteria: A Systematic Review and Meta-Analysis.
Topics: Abortion, Spontaneous; Female; Humans; Hypothyroidism; Infant, Newborn; Pregnancy; Pregnancy Outcome | 2021 |
Systematic review and meta-analysis of the efficacy and pregnancy outcomes of levothyroxine sodium tablet administration in pregnant women complicated with hypothyroidism.
Topics: Abortion, Spontaneous; Female; Humans; Hypertension, Pregnancy-Induced; Hypothyroidism; Infant, Newb | 2022 |
The impact of levothyroxine therapy on the pregnancy, neonatal and childhood outcomes of subclinical hypothyroidism during pregnancy: An updated systematic review, meta-analysis and trial sequential analysis.
Topics: Abortion, Spontaneous; Child; Female; Humans; Hypothyroidism; Infant, Newborn; Pregnancy; Pregnancy | 2022 |
Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis.
Topics: Birth Weight; Diabetes, Gestational; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Prem | 2023 |
Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis.
Topics: Birth Weight; Diabetes, Gestational; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Prem | 2023 |
Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis.
Topics: Birth Weight; Diabetes, Gestational; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Prem | 2023 |
Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis.
Topics: Birth Weight; Diabetes, Gestational; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Prem | 2023 |
Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis.
Topics: Birth Weight; Diabetes, Gestational; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Prem | 2023 |
Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis.
Topics: Birth Weight; Diabetes, Gestational; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Prem | 2023 |
Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis.
Topics: Birth Weight; Diabetes, Gestational; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Prem | 2023 |
Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis.
Topics: Birth Weight; Diabetes, Gestational; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Prem | 2023 |
Obstetric and offspring outcomes in isolated maternal hypothyroxinaemia: a systematic review and meta-analysis.
Topics: Birth Weight; Diabetes, Gestational; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Prem | 2023 |
A Systematic Review and Meta-Analysis Examining the Risk of Adverse Pregnancy and Neonatal Outcomes in Women with Isolated Hypothyroxinemia in Pregnancy.
Topics: Diabetes, Gestational; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Outcome; Premature Birt | 2023 |
Effect of levothyroxine on the pregnancy outcomes in recurrent pregnancy loss women with subclinical hypothyroidism and thyroperoxidase antibody positivity: a systematic review and meta-analysis.
Topics: Abortion, Habitual; Female; Humans; Hypothyroidism; Pregnancy; Pregnancy Outcome; Premature Birth; T | 2023 |
Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Female; Gestational Age; Humans; Hypothyroidism; Infant, | 2019 |
[Effect of levothyroxine treatment on pregnancy outcomes in euthyroid women with thyroid autoantibody positive: a Meta-analysis].
Topics: Autoantibodies; China; Female; Humans; Hypothyroidism; Infant, Newborn; Pregnancy; Pregnancy Complic | 2021 |
Impact of levothyroxine in women with positive thyroid antibodies on pregnancy outcomes: a systematic review and meta-analysis of randomised controlled trials.
Topics: Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications; Premature Birth; Randomized Con | 2021 |
Understanding the Pathogenesis of Gestational Hypothyroidism.
Topics: Abortion, Spontaneous; Abruptio Placentae; Animals; Estrogens; Female; Fetal Death; Humans; Hypothyr | 2021 |
Pregnancy Complications Associated With Maternal Hypothyroidism: A Systematic Review.
Topics: Abortion, Spontaneous; Female; Fetal Death; Humans; Hypothyroidism; Infant, Newborn; Maternal-Fetal | 2018 |
Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta-analysis.
Topics: Abortion, Spontaneous; Autoantibodies; Autoimmunity; Dietary Supplements; Female; Humans; Hypothyroi | 2019 |
Hypothyroidism in Pregnancy.
Topics: Abortion, Spontaneous; Antibodies; Clinical Trials as Topic; Female; Fetal Development; Humans; Hypo | 2019 |
Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy.
Topics: Abortion, Spontaneous; Female; Hormone Replacement Therapy; Humans; Hypothyroidism; Pre-Eclampsia; P | 2013 |
The impact of maternal hypothyroidism during pregnancy on neonatal outcomes: a systematic review and meta-analysis.
Topics: Birth Weight; Female; Fetal Macrosomia; Hormone Replacement Therapy; Humans; Hypothyroidism; Infant, | 2016 |
Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis.
Topics: Abortion, Spontaneous; Female; Humans; Hypothyroidism; Pregnancy; Pregnancy Complications; Pregnancy | 2016 |
[Obstetrical complications of thyroid peroxidase antibody positive during pregnancy and effects of intervention: a meta-analysis].
Topics: Abortion, Spontaneous; Autoantibodies; China; Cohort Studies; Female; Humans; Iodide Peroxidase; Pre | 2016 |
The Impact and Management of Subclinical Hypothyroidism for Improving Reproductive Outcomes such as Fertility and Miscarriage.
Topics: Abortion, Spontaneous; Biomarkers; Developmental Disabilities; Female; Fertility; Humans; Hypothyroi | 2016 |
Interventions for clinical and subclinical hypothyroidism in pregnancy.
Topics: Abortion, Spontaneous; Female; Hormone Replacement Therapy; Humans; Hypothyroidism; Pre-Eclampsia; P | 2010 |
Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence.
Topics: Abortion, Spontaneous; Autoantibodies; Female; Humans; Maternal Age; Pregnancy; Pregnancy Outcome; P | 2011 |
Thyroid disorders during pregnancy.
Topics: Abortion, Spontaneous; Diet; Female; Hormone Replacement Therapy; Humans; Hypothyroidism; Iodine; Ma | 2012 |
2 trials available for thyroxine and Preterm Birth
Article | Year |
---|---|
Association between Hypertensive Disorders of Pregnancy and Long-Term Neurodevelopmental Outcomes in the Offspring.
Topics: Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Language Development Disorders; Pr | 2022 |
Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies.
Topics: Adult; Autoantibodies; Autoantigens; Female; Gestational Age; Humans; Hypothyroidism; Infant, Newbor | 2018 |
39 other studies available for thyroxine and Preterm Birth
Article | Year |
---|---|
Effects of isolated maternal hypothyroxinemia on adverse pregnancy outcomes.
Topics: Female; Humans; Infant, Newborn; Iran; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premat | 2022 |
Neonatal outcomes and congenital anomalies in pregnancies affected by hypothyroidism.
Topics: Adult; Birth Weight; Cesarean Section; Cross-Sectional Studies; Female; Fetal Distress; Humans; Hypo | 2021 |
A Novel Nomogram for Predicting the Risk of Premature Delivery Based on the Thyroid Function in Pregnant Women.
Topics: Adolescent; Adult; Autoantibodies; China; Clinical Decision Rules; Diabetes, Gestational; Female; Hu | 2021 |
Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment.
Topics: Female; Hashimoto Disease; Humans; Hypothyroidism; Infant, Newborn; Male; Pregnancy; Premature Birth | 2022 |
The targeted high-risk case-finding approach versus universal screening for thyroid dysfunction during pregnancy: thyroid-stimulating hormone (TSH) and/or thyroid peroxidase antibody (TPOAb) test?
Topics: Autoantibodies; Female; Humans; Hypothyroidism; Infant, Newborn; Iodide Peroxidase; Iran; Pregnancy; | 2022 |
Euthyroid Thyroperoxidase Antibody Positivity during Pregnancy, to Treat or Not to Treat?
Topics: Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications; Premature Birth; Thyroid Diseas | 2022 |
Thyroid Function Rather Than Thyroid Antibodies Affects Pregnancy and Perinatal Outcomes: Results of a Prospective Study.
Topics: Abortion, Spontaneous; Autoantibodies; Female; Humans; Infant, Newborn; Pregnancy; Premature Birth; | 2022 |
Maternal subclinical hyperthyroidism and adverse pregnancy outcomes considering the iodine status: Tehran thyroid and pregnancy study.
Topics: Female; Humans; Hyperthyroidism; Infant, Newborn; Iodide Peroxidase; Iodides; Iodine; Iran; Pregnanc | 2022 |
Clinical features and outcomes of 31 children with congenital hypothyroidism missed by neonatal screening.
Topics: Child, Preschool; Congenital Hypothyroidism; Dual Oxidases; Female; Humans; Infant, Newborn; Neonata | 2022 |
Association of maternal levothyroxine use during pregnancy with offspring birth and neurodevelopmental outcomes: a population-based cohort study.
Topics: Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Cohort Studies; Female; Hum | 2022 |
A Bayesian model to estimate the cutoff value of TSH for management of preterm birth.
Topics: Bayes Theorem; Female; Humans; Infant, Newborn; Iodide Peroxidase; Iodine; Iran; Pregnancy; Prematur | 2023 |
Association between third trimester maternal isolated hypothyroxinemia and adverse pregnancy outcomes.
Topics: Adult; Female; Fetal Distress; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications; Pregnanc | 2023 |
Effect of extra-low dose levothyroxine supplementation on pregnancy outcomes in women with subclinical hypothyroidism undergoing in vitro fertilization and embryo transfer.
Topics: Abortion, Spontaneous; Adult; Dietary Supplements; Embryo Transfer; Female; Fertilization in Vitro; | 2023 |
First-trimester placental function in levothyroxine-using pregnant women: a case-control study.
Topics: Adolescent; Adult; Birth Weight; Case-Control Studies; Cesarean Section; Chorionic Gonadotropin, bet | 2020 |
Hypothyroidism and pregnancy: still a controversial issue.
Topics: Adult; Autoantibodies; Cohort Studies; Female; Hormone Replacement Therapy; Humans; Hypothyroidism; | 2020 |
The Association Between Isolated Maternal Hypothyroxinemia in Early Pregnancy and Preterm Birth.
Topics: Adult; Biomarkers; Case-Control Studies; Down-Regulation; Female; Gestational Age; Humans; Hypothyro | 2020 |
Impact of maternal thyroid hormone in late pregnancy on adverse birth outcomes: A retrospective cohort study in China.
Topics: Adult; China; Cohort Studies; Female; Fetal Macrosomia; Humans; Hyperthyroidism; Hyperthyroxinemia; | 2021 |
Association of thyroid antibodies status on the outcomes of pregnant women with hypothyroidism (maternal hypothyroidism on pregnancy outcomes, MHPO-4).
Topics: Abortion, Spontaneous; Abruptio Placentae; Adult; Apgar Score; Autoantibodies; Autoimmune Diseases; | 2021 |
Thyroid hormone parameters during pregnancy in relation to urinary bisphenol A concentrations: A repeated measures study.
Topics: Adolescent; Adult; Benzhydryl Compounds; Case-Control Studies; Environmental Pollutants; Female; Hum | 2017 |
Thyroid-stimulating hormone, anti-thyroid antibodies, and pregnancy outcomes.
Topics: Adult; Asymptomatic Diseases; Autoantibodies; Cohort Studies; Diabetes, Gestational; Female; Humans; | 2017 |
Subclinical Changes in Maternal Thyroid Function Parameters in Pregnancy and Fetal Growth.
Topics: Adolescent; Adult; Asymptomatic Diseases; Birth Weight; Case-Control Studies; Female; Fetal Developm | 2018 |
Maternal and placental responses before preterm birth: adaptations to increase fetal thyroid hormone availability?
Topics: Adult; Case-Control Studies; Female; Humans; Hypothyroidism; Infant, Newborn; Male; Placenta; Pregna | 2019 |
IMPORTANCE OF ISOLATED GESTATIONAL HYPOTHYROXINEMIA IN THE DEVELOPMENT OF OBSTETRIC AND SOMATIC PATHOLOGIES.
Topics: Abortion, Spontaneous; Adolescent; Adult; Alopecia; Case-Control Studies; Diabetes Mellitus; Female; | 2018 |
Pregnancy and Perinatal Outcome Among Hypothyroid Mothers: A Population-Based Cohort Study.
Topics: Adult; Cesarean Section; Diabetes, Gestational; Female; Humans; Hypertension, Pregnancy-Induced; Hyp | 2019 |
Pregnancy outcomes in women with severe hypothyroidism.
Topics: Abortion, Spontaneous; Adult; Female; Graves Disease; Hashimoto Disease; Hormone Replacement Therapy | 2013 |
Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study.
Topics: Adult; Autoantibodies; Female; Fetal Membranes, Premature Rupture; Humans; Hyperthyroidism; Hypothyr | 2013 |
Is total thyroxine better than free thyroxine during pregnancy?
Topics: Abruptio Placentae; Adult; Female; Gestational Age; Humans; Hypothyroidism; Pregnancy; Pregnancy Com | 2014 |
Maternal thyroid dysfunction during gestation, preterm delivery, and birthweight. The Infancia y Medio Ambiente Cohort, Spain.
Topics: Adult; Birth Weight; Female; Gestational Age; Humans; Hypothyroidism; Infant, Newborn; Iodine; Mothe | 2015 |
Thyroid function and autoimmunity in Danish pregnant women after an iodine fortification program and associations with obstetric outcomes.
Topics: Adult; Autoantibodies; Autoimmunity; Cohort Studies; Denmark; Female; Food, Fortified; Gestational A | 2015 |
[Effect of the treatment acceptance on the perinatal outcomes in women with subclinical hypothyroidism, positive thyroid gland peroxidase antibody in early pregnancy].
Topics: Abortion, Spontaneous; Autoantibodies; Case-Control Studies; Diabetes, Gestational; Female; Humans; | 2015 |
Effects of Levothyroxine Therapy on Pregnancy Outcomes in Women with Subclinical Hypothyroidism.
Topics: Abortion, Spontaneous; Adult; Apgar Score; Asymptomatic Diseases; Case-Control Studies; Diabetes, Ge | 2016 |
Impact of Levothyroxine in Miscarriage and Preterm Delivery Rates in First Trimester Thyroid Antibody-Positive Women With TSH Less Than 2.5 mIU/L.
Topics: Abortion, Spontaneous; Adolescent; Adult; Autoantibodies; Autoantigens; Female; Humans; Iodide Perox | 2016 |
Thyroid Autoimmunity Impairs the Thyroidal Response to Human Chorionic Gonadotropin: Two Population-Based Prospective Cohort Studies.
Topics: Adult; Autoantibodies; Autoantigens; Autoimmunity; Chorionic Gonadotropin; Female; Follow-Up Studies | 2017 |
Detection of circulating autoantibodies against thyroid hormones in an infant with permanent congenital hypothyroidism and her twin with transient congenital hypothyroidism: possible contribution of thyroid hormone autoantibodies to neonatal and infant hy
Topics: Autoantibodies; Autoantigens; Body Height; Body Weight; Child, Preschool; Congenital Hypothyroidism; | 2008 |
Thyroid function and autoantibody status among women who spontaneously deliver under 35 weeks of gestation.
Topics: Adult; Autoantibodies; Case-Control Studies; Female; Humans; Iodide Peroxidase; Pregnancy; Pregnancy | 2009 |
Visual abilities at 6 months in preterm infants: impact of thyroid hormone deficiency and neonatal medical morbidity.
Topics: Analysis of Variance; Color Perception; Contrast Sensitivity; Female; Humans; Hypothyroidism; Infant | 2010 |
Maternal thyroid function at 11-13 weeks of gestation and spontaneous preterm delivery.
Topics: Adult; Antibodies; Female; Humans; Iodide Peroxidase; Pregnancy; Pregnancy Trimester, First; Prematu | 2011 |
The natural history of the hyperthyrotropinemia of children born prematurely.
Topics: Adolescent; Autoantibodies; Autoantigens; Blood Glucose; Child; Child, Preschool; Congenital Hypothy | 2012 |
Mild maternal thyroid dysfunction at delivery of infants born ≤34 weeks and neurodevelopmental outcome at 5.5 years.
Topics: Adult; Autoantibodies; Brain; Child Development; Child, Preschool; Cognition; Female; Follow-Up Stud | 2012 |